Mr. Rajiv Gulati is currently President-Global Pharmaceuticals Business, for Ranbaxy Laboratories Limited, located at their Global Headquarters, Gurgaon.  Before joining Ranbaxy in April, 2011, he was head of Emerging Market Strategy for Eli Lilly & Co., working at their Global Head Office at Indianapolis, USA.

He was responsible for directing the strategy for globalization, driving significant improvements in global sourcing, structure and processes leading to enhanced cross functional coordination and productivity.  He has contributed to significant growth in sales, creating one of the fastest start up businesses, executing business critical deals including in-licensing and out-licensing of technologies and products, creation and implementation of a long term strategy for Eli Lilly in the fast growing economies across functions like Demand Realization, Research and Development, IT and Manufacturing.

He has been the recipient of a number of awards like the Chairman's Ovation Award, Eli Lilly and Company, Indianapolis, Top CEO Award at the 29th World Marketing Conference, KC Chatterjee Memorial Award, Indian Pharmaceutical Association among others.

Some of the positions he has held as part of his affiliations in the Industry and Academia include Vice President, Organization of Pharmaceutical Producers of India, Chair - Pharmaceutical Industry, American Chamber of Commerce, New Delhi, Chair-Pharmaceutical Industry, Indo-American Chamber of Commerce, New Delhi,  Advisory Board Member, Narsee Monjee Institute of Management, Mumbai and Advisory Board Member, National Institute of Pharmaceutical Education and Research.

He has also been associated as guest faculty with premier academic Institutes like Indian Institute of Management, Indian Institute of Foreign Trade, Graduate School of Business, Chicago, Richard Ivey Business School, Canada, Kelley School of Business, Indiana University and Wharton.